---
title: "Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294363759.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-30T09:41:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294363759.md)
  - [en](https://longbridge.com/en/news/294363759.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294363759.md)
generator: "portal-rs"
---

# Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [Nilsine Partners LLC Makes New Investment in Amgen Inc. $AMGN](https://longbridge.com/en/news/298130227.md)
- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [Peptide innovator says the drug class is due for a rethink](https://longbridge.com/en/news/297803292.md)
- [Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance](https://longbridge.com/en/news/298273759.md)
- [Firefox for iOS Gets Built-In Ad Blocker](https://longbridge.com/en/news/297656638.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**